These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 16809213)

  • 41. Efficacy of botulinum toxin-A for treating idiopathic detrusor overactivity: results from a single center, randomized, double-blind, placebo controlled trial.
    Sahai A; Khan MS; Dasgupta P
    J Urol; 2007 Jun; 177(6):2231-6. PubMed ID: 17509328
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A randomized controlled study of botulinum toxin A in the treatment of hemiplegic shoulder pain associated with spasticity.
    Kong KH; Neo JJ; Chua KS
    Clin Rehabil; 2007 Jan; 21(1):28-35. PubMed ID: 17213238
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Management of shoulder and proximal upper limb spasticity using botulinum toxin and concurrent therapy interventions: a preliminary analysis of goals and outcomes.
    Ashford S; Turner-Stokes L
    Disabil Rehabil; 2009; 31(3):220-6. PubMed ID: 18608366
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Botulinum toxin type-A and plaster cast treatment in children with upper brachial plexus palsy.
    Basciani M; Intiso D
    Pediatr Rehabil; 2006; 9(2):165-70. PubMed ID: 16449076
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Botulinum toxin type-A (BOTOX) in the treatment of occipital neuralgia: a pilot study.
    Taylor M; Silva S; Cottrell C
    Headache; 2008; 48(10):1476-81. PubMed ID: 19076646
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Predictors of response to botulinum toxin type A (BoNTA) in chronic daily headache.
    Mathew NT; Kailasam J; Meadors L
    Headache; 2008 Feb; 48(2):194-200. PubMed ID: 17868356
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pilot study of botulinum toxin type A in the treatment of chronic pelvic pain associated with spasm of the levator ani muscles.
    Jarvis SK; Abbott JA; Lenart MB; Steensma A; Vancaillie TG
    Aust N Z J Obstet Gynaecol; 2004 Feb; 44(1):46-50. PubMed ID: 15089868
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Botulinum toxin A versus bupivacaine trigger point injections for the treatment of myofascial pain syndrome: a randomised double blind crossover study.
    Graboski CL; Gray DS; Burnham RS
    Pain; 2005 Nov; 118(1-2):170-5. PubMed ID: 16202527
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Single CT-guided chemodenervation of the anterior scalene muscle with botulinum toxin for neurogenic thoracic outlet syndrome.
    Christo PJ; Christo DK; Carinci AJ; Freischlag JA
    Pain Med; 2010 Apr; 11(4):504-11. PubMed ID: 20202146
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Repeated treatments with botulinum toxin type a produce sustained decreases in the limitations associated with focal upper-limb poststroke spasticity for caregivers and patients.
    Elovic EP; Brashear A; Kaelin D; Liu J; Millis SR; Barron R; Turkel C
    Arch Phys Med Rehabil; 2008 May; 89(5):799-806. PubMed ID: 18452724
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Botulinum toxin (Dysport) treatment of the spastic gastrocnemius muscle in children with cerebral palsy: a randomized trial comparing two injection volumes.
    Hu GC; Chuang YC; Liu JP; Chien KL; Chen YM; Chen YF
    Clin Rehabil; 2009 Jan; 23(1):64-71. PubMed ID: 19114438
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The therapeutic use of botulinum toxin in cervical and maxillofacial conditions: an evidence-based review.
    Ihde SK; Konstantinovic VS
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Aug; 104(2):e1-11. PubMed ID: 17560141
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficacy of botulinum toxin type A for the prophylaxis of episodic migraine headaches: a meta-analysis of randomized, double-blind, placebo-controlled trials.
    Shuhendler AJ; Lee S; Siu M; Ondovcik S; Lam K; Alabdullatif A; Zhang X; Machado M; Einarson TR
    Pharmacotherapy; 2009 Jul; 29(7):784-91. PubMed ID: 19558252
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Delayed vastus medialis obliquus to vastus lateralis onset timing contributes to the development of patellofemoral pain in previously healthy men: a prospective study.
    Van Tiggelen D; Cowan S; Coorevits P; Duvigneaud N; Witvrouw E
    Am J Sports Med; 2009 Jun; 37(6):1099-105. PubMed ID: 19282508
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Treatment of axillary hyperhidrosis with botulinum toxin type A reconstituted in lidocaine or in normal saline: a randomized, side-by-side, double-blind study.
    Vadoud-Seyedi J; Simonart T
    Br J Dermatol; 2007 May; 156(5):986-9. PubMed ID: 17286630
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The analgesic effect of botulinum-toxin A on postwhiplash neck pain.
    Braker C; Yariv S; Adler R; Badarny S; Eisenberg E
    Clin J Pain; 2008 Jan; 24(1):5-10. PubMed ID: 18180629
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Quadriceps activity and movement reactions in response to unpredictable sagittal support-surface translations in women with patellofemoral pain.
    Stensdotter AK; Grip H; Hodges PW; Häger-Ross C
    J Electromyogr Kinesiol; 2008 Apr; 18(2):298-307. PubMed ID: 17158068
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Experimental quadriceps muscle pain impairs knee joint control during walking.
    Henriksen M; Alkjaer T; Lund H; Simonsen EB; Graven-Nielsen T; Danneskiold-Samsøe B; Bliddal H
    J Appl Physiol (1985); 2007 Jul; 103(1):132-9. PubMed ID: 17412791
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Botulinum toxin A for the management of vulvodynia.
    Yoon H; Chung WS; Shim BS
    Int J Impot Res; 2007; 19(1):84-7. PubMed ID: 16728964
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Improved intramuscular blood flow and normalized metabolism in lateral epicondylitis after botulinum toxin treatment.
    Oskarsson E; Piehl Aulin K; Gustafsson BE; Pettersson K
    Scand J Med Sci Sports; 2009 Jun; 19(3):323-8. PubMed ID: 18435689
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.